
Castle Biosciences CSTL
€ 21.94
-1.2%
Quartalsbericht 2025-Q3
hinzugefügt 03.11.2025
Castle Biosciences EV/EBITDA 2011-2026 | CSTL
EV/EBITDA Jährlich Castle Biosciences
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -21.2 | -142 | 24 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 24 | -142 | -46.4 |
EV/EBITDA anderer Aktien in der Diagnostik & Forschung
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Biodesix
BDSX
|
-4.25 | $ 15.21 | 3.54 % | $ 1.97 B | ||
|
Bioventus
BVS
|
26.4 | $ 9.12 | 1.33 % | $ 608 M | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.12 | -0.47 % | $ 4.87 M | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 16.37 | 0.24 % | $ 495 M | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 75.01 | -0.96 % | $ 5.06 B | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 460.9 | 0.87 % | $ 13.3 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Myriad Genetics
MYGN
|
-17.2 | $ 4.77 | 2.36 % | $ 442 M | ||
|
National Research Corporation
NRC
|
21 | $ 17.42 | -0.51 % | $ 390 M | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Pacific Biosciences of California
PACB
|
-23.8 | $ 1.39 | -0.36 % | $ 417 M | ||
|
Co-Diagnostics
CODX
|
3.62 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
Precipio
PRPO
|
-1.8 | $ 26.85 | -0.3 % | $ 34.8 M | ||
|
Personalis
PSNL
|
-7.07 | $ 7.7 | 1.18 % | $ 456 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
RadNet
RDNT
|
17.6 | $ 60.0 | -2.83 % | $ 4.51 B | ||
|
Charles River Laboratories International
CRL
|
22 | $ 159.79 | 1.13 % | $ 7.92 B | ||
|
IQVIA Holdings
IQV
|
24.1 | $ 165.38 | -0.95 % | $ 28.4 B | ||
|
Senseonics Holdings
SENS
|
-13.8 | $ 6.74 | 1.81 % | $ 281 M | ||
|
Sotera Health Company
SHC
|
24.8 | $ 13.89 | 0.07 % | $ 3.94 B | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
-10.7 | - | - | $ 21.2 M | ||
|
BioNano Genomics
BNGO
|
-7.71 | $ 1.24 | -15.07 % | $ 6.75 M | ||
|
Neuronetics
STIM
|
-1.45 | $ 1.49 | -7.19 % | $ 98.3 M | ||
|
Mettler-Toledo International
MTD
|
827 | $ 1 256.48 | 1.41 % | $ 25.9 B | ||
|
Interpace Biosciences
IDXG
|
-6.02 | $ 1.71 | 0.73 % | $ 7.5 M | ||
|
IDEXX Laboratories
IDXX
|
45.3 | $ 574.14 | -0.76 % | $ 46.2 B | ||
|
Illumina
ILMN
|
70.5 | $ 125.44 | 1.33 % | $ 19.9 B | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 101.04 | 0.68 % | $ 8.33 B | ||
|
Guardant Health
GH
|
-28.8 | $ 85.0 | 0.05 % | $ 10.7 B | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Twist Bioscience Corporation
TWST
|
-23.6 | $ 45.99 | 3.35 % | $ 2.75 B | ||
|
Celcuity
CELC
|
-2.38 | $ 103.41 | -3.13 % | $ 4.08 B | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 265.75 | 0.5 % | $ 22.1 B | ||
|
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | ||
|
ENDRA Life Sciences
NDRA
|
0.831 | $ 3.36 | -3.45 % | $ 1.8 M | ||
|
NeoGenomics
NEO
|
-33.5 | $ 8.05 | -0.62 % | $ 1.03 B | ||
|
Natera
NTRA
|
-19.5 | $ 195.23 | -2.43 % | $ 19.2 B | ||
|
CareDx, Inc
CDNA
|
-100 | $ 17.58 | 0.11 % | $ 937 M |